Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06271096Phase 1Completed
Phase 1, randomised, open-label trial of midazolam in epilepsy (2 arms). Primary endpoint: Fits Controlled. Started Nov 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06271096.